GIM
ONC

Generali Investments Management’s BeOne Medicines Ltd ONC Stock Holding History

Generali Investments Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$174K Buy
+8,000
New +$2.36M 0.04% 146
2026
Q1 		– Sell
-8,000
Closed -$184K – 171
2025
Q4 		$184K Hold
8,000
– – 0.04% 132
2025
Q3 		$211K Buy
+8,000
New +$2.43M 0.04% 136
2025
Q2 		– Sell
-5,000
Closed -$107K – 166
2025
Q1 		$107K Buy
+5,000
New +$1.17M 0.03% 130

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Generali Investments Management's ONC Position: Q2 2026 in Review

Generali Investments Management opened a new position in BeOne Medicines Ltd (ONC) in Q2 2026: 8,000 shares worth $174K. The stake represents 0.04% of the portfolio and ranks #146 among its holdings. This is a return to the name: Generali Investments Management previously reported a position in ONC as recently as Q4 2025.

Generali Investments Management first reported a position in ONC in Q1 2025 and has held it in 4 quarters since. The position peaked at $211K in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Generali Investments Management held 8,000 shares of BeOne Medicines Ltd worth $174K as of Q2 2026.
  • BeOne Medicines Ltd was a new Generali Investments Management position in Q2 2026.
  • BeOne Medicines Ltd made up 0.04% of Generali Investments Management's portfolio in Q2 2026, its #146 holding.
  • Generali Investments Management first reported a position in BeOne Medicines Ltd in Q1 2025 and has held it in 4 quarters since.
  • Generali Investments Management's BeOne Medicines Ltd position peaked at $211K in Q3 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Generali Investments Management's 13F filing for Q2 2026, filed 10 Jul 2026.